GlassScriptPhysician profile
Zaira J Moreno
NPI 1750401642
$1,835.62
in general payments reported to CMS, 2019-2025
27 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $58.06 · 2021: $371 · 2022: $340 · 2023: $323 · 2024: $312 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.78 | 2019-2024 | |
| Pfizer INC. | $220.13 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $148.68 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $127.54 | 2021-2024 | Slynd |
| Evofem Biosciences, INC. | $111.08 | 2021-2022 | |
| Organon LLC | $108.46 | 2021-2024 | |
| Astellas Pharma US INC | $100.63 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $92.49 | 2020-2024 | Summit Doppler, Paragard T 380a |
| Merck Sharp & Dohme LLC | $67.61 | 2019-2025 | Gardasil 9 |
| Myovant Sciences INC. | $65.25 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $63.73 | 2021-2022 | |
| Sage Therapeutics, LLC | $57.77 | 2024-2025 | Zurzuvae |
| Meditrina | $45.44 | 2023-2025 | |
| Duchesnay USA Incorporated | $45.08 | 2019 | |
| Mayne Pharma Commercial LLC | $39.40 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $35.87 | 2021 | |
| Gynesonics, INC. | $33.17 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $31.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.32 | 2019 | |
| Agile Therapeutics, INC. | $24.97 | 2021-2022 | |
| Millicent US INC | $21.54 | 2020 | |
| Medical Device Business Services, INC. | $20.53 | 2020 | |
| Mimedx Group, INC. | $19.70 | 2024 | |
| Daiichi Sankyo INC. | $18.75 | 2023 | Injectafer |
| Applied Medical Resources Corporation | $16.82 | 2023 | |
| Minerva Surgical, INC | $14.44 | 2022 | |
| Therapeuticsmd, INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaira Moreno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.